Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Ritter, Heather D ^a,b   Mueller, Christopher R ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

BRCA1; Breast cancer; Expression microarray; Glucocorticoid receptor; Hydrocortisone; Unliganded

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; BRCA1 PROTEIN; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MIFEPRISTONE; SHORT HAIRPIN RNA;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CH25H GENE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; HSD11B1 GENE; MOUSE; NONHUMAN; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; APOPTOSIS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE; DRUG EFFECTS; EPITHELIUM CELL; FEMALE; GENETICS; METABOLISM; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UDDER;

ANIMALS; APOPTOSIS; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; MAMMARY GLANDS, ANIMAL; MICE; MICROARRAY ANALYSIS; PROMOTER REGIONS, GENETIC; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84899488818     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-275     Document Type: Article

References (74)

1. Reichardt HM, Horsch K, Grone HJ, Kolbus A, Beug H, Hynes N, Schutz G. Mammary gland development and lactation are controlled by different glucocorticoid receptor activities. Eur J Endocrinol 2001, 145(4):519-527. 10.1530/eje.0.1450519, 11581013.
2. Majumder PK, Joshi JB, Banerjee MR. Correlation between nuclear glucocorticoid receptor levels and casein gene expression in murine mammary gland in vitro. J Biol Chem 1983, 258(11):6793-6798.
3. Watson CJ. Post-lactational mammary gland regression: molecular basis and implications for breast cancer. Expert Rev Mol Med 2006, 8(32):1-15.
4. Hoijman E, Rocha-Viegas L, Kalko SG, Rubinstein N, Morales-Ruiz M, Joffe EB, Kordon EC, Pecci A. Glucocorticoid alternative effects on proliferating and differentiated mammary epithelium are associated to opposite regulation of cell-cycle inhibitor expression. J Cell Physiol 2012, 227(4):1721-1730. 10.1002/jcp.22896, 21688264.
5. Lien HC, Lu YS, Cheng AL, Chang WC, Jeng YM, Kuo YH, Huang CS, Chang KJ, Yao YT. Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms. J Pathol 2006, 209(3):317-327. 10.1002/path.1982, 16639692.
6. Buxant F, Engohan-Aloghe C, Noel JC. Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer. Appl Immunohistochem Mol Morphol 2010, 18(3):254-257. 10.1097/PAI.0b013e3181c10180, 19875955.
7. Courtin A, Communal L, Vilasco M, Cimino D, Mourra N, de Bortoli M, Taverna D, Faussat AM, Chaouat M, Forgez P, Gompel A. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells. Breast Cancer Res Treat 2012, 131(1):49-63. 10.1007/s10549-011-1394-5, 21336598.
8. Peeters BW, Tonnaer JA, Groen MB, Broekkamp CL, van der Voort HA, Schoonen WG, Smets RJ, Vanderheyden PM, Gebhard R, Ruigt GS. Glucocorticoid receptor antagonists: new tools to investigate disorders characterized by cortisol hypersecretion. Stress 2004, 7(4):233-241. 10.1080/10253890400019672, 16019588.
9. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schutz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998, 93(4):531-541. 10.1016/S0092-8674(00)81183-6, 9604929.
10. Wintermantel TM, Bock D, Fleig V, Greiner EF, Schutz G. The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production. Mol Endocrinol 2005, 19(2):340-349. 10.1210/me.2004-0068, 15471946.
11. Tronche F, Kellendonk C, Reichardt HM, Schutz G. Genetic dissection of glucocorticoid receptor function in mice. Curr Opin Genet Dev 1998, 8(5):532-538. 10.1016/S0959-437X(98)80007-5, 9794823.
12. Murtagh J, McArdle E, Gilligan E, Thornton L, Furlong F, Martin F. Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling. J Cell Biol 2004, 166(1):133-143. 10.1083/jcb.200403020, 2172147, 15226308.
13. Ritter HD, Antonova L, Mueller CR. The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta. Mol Cancer Res 2012, 10(4):558-569. 10.1158/1541-7786.MCR-11-0423-T, 22328717.
14. Weigel NL, Zhang Y. Ligand-independent activation of steroid hormone receptors. J Mol Med (Berl) 1998, 76(7):469-479. 10.1007/s001090050241, 9660165.
15. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 2004, 64(5):1757-1764. 10.1158/0008-5472.CAN-03-2546, 14996737.
16. So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 2007, 3(6):e94. 10.1371/journal.pgen.0030094, 1904358, 17559307.
17. Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, Garabedian MJ, Myers RM. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res 2009, 19(12):2163-2171. 10.1101/gr.097022.109, 2792167, 19801529.
18. Fialka I, Schwarz H, Reichmann E, Oft M, Busslinger M, Beug H. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J Cell Biol 1996, 132(6):1115-1132. 10.1083/jcb.132.6.1115, 2120757, 8601589.
19. Antonova L, Mueller CR. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer. Genes Chromosomes Cancer 2008, 47(4):341-352. 10.1002/gcc.20538, 18196591.
20. MacDonald G, Stramwasser M, Mueller CR. Characterization of a negative transcriptional element in the BRCA1 promoter. Breast Cancer Res 2007, 9(4):R49. 10.1186/bcr1753, 2206725, 17663789.
21. Pearce D, Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 1993, 259(5098):1161-1165. 10.1126/science.8382376, 8382376.
22. Watanabe H, Sawada J, Yano K, Yamaguchi K, Goto M, Handa H. cDNA cloning of transcription factor E4TF1 subunits with Ets and notch motifs. Mol Cell Biol 1993, 13(3):1385-1391. 359448, 8441384.
23. Thompson C, Macdonald G, Mueller CR. Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex. Mol Cancer 2011, 10(1):62. 10.1186/1476-4598-10-62, 3127848, 21609478.
24. Zheng Q, Wang XJ. GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res 2008, 36(Web Server issue):W358-W363. 2447756, 18487275.
25. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30(1):207-210. 10.1093/nar/30.1.207, 99122, 11752295.
26. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004, 25(5):831-866. 10.1210/er.2003-0031, 15466942.
27. McDonald JG, Russell DW. Editorial: 25-Hydroxycholesterol: a new life in immunology. J Leukoc Biol 2010, 88(6):1071-1072. 10.1189/jlb.0710418, 2996897, 21123296.
28. Diczfalusy U, Olofsson KE, Carlsson AM, Gong M, Golenbock DT, Rooyackers O, Flaring U, Bjorkbacka H. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J Lipid Res 2009, 50(11):2258-2264. 10.1194/jlr.M900107-JLR200, 2759831, 19502589.
29. Bauman DR, Bitmansour AD, McDonald JG, Thompson BM, Liang G, Russell DW. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc Natl Acad Sci U S A 2009, 106(39):16764-16769. 10.1073/pnas.0909142106, 2757821, 19805370.
30. Ouimet M, Marcel YL. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol 2012, 32(3):575-581. 10.1161/ATVBAHA.111.240705, 22207731.
31. Justesen J, Hartmann R, Kjeldgaard NO. Gene structure and function of the 2′-5'-oligoadenylate synthetase family. Cell Mol Life Sci 2000, 57(11):1593-1612. 10.1007/PL00000644, 11092454.
32. Solinas A, Cossu P, Poddighe P, Tocco A, Deplano A, Garrucciu G, Diana MS. Changes of serum 2′,5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis C. Liver 1993, 13(5):253-258.
33. Tazawa S, Yamato T, Fujikura H, Hiratochi M, Itoh F, Tomae M, Takemura Y, Maruyama H, Sugiyama T, Wakamatsu A, Isogai T, Isaji M. SLC5A9/SGLT4, a new Na + -dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci 2005, 76(9):1039-1050. 10.1016/j.lfs.2004.10.016, 15607332.
34. Mahajan DK, London SN. Mifepristone (RU486): a review. Fertil Steril 1997, 68(6):967-976. 10.1016/S0015-0282(97)00189-1, 9418681.
35. Wang JH, Tuohimaa P. Regulation of cholesterol 25-hydroxylase expression by vitamin D3 metabolites in human prostate stromal cells. Biochem Biophys Res Commun 2006, 345(2):720-725. 10.1016/j.bbrc.2006.04.156, 16696936.
36. Lund EG, Kerr TA, Sakai J, Li WP, Russell DW. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J Biol Chem 1998, 273(51):34316-34327. 10.1074/jbc.273.51.34316, 9852097.
37. Barry MA, Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys 1993, 300(1):440-450. 10.1006/abbi.1993.1060, 8424678.
38. Ricketts ML, Shoesmith KJ, Hewison M, Strain A, Eggo MC, Stewart PM. Regulation of 11 beta-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes. J Endocrinol 1998, 156(1):159-168. 10.1677/joe.0.1560159, 9496245.
39. Cai TQ, Wong B, Mundt SS, Thieringer R, Wright SD, Hermanowski-Vosatka A. Induction of 11beta-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli. J Steroid Biochem Mol Biol 2001, 77(2-3):117-122.
40. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001, 142(5):1982-1989.
41. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270(5234):286-290. 10.1126/science.270.5234.286, 7569976.
42. Fischer T, Aman J, van der Kuip H, Rudolf G, Peschel C, Aulitzky WE, Huber C. Induction of interferon regulatory factors 2′-5' oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness. Br J Haematol 1996, 92(3):595-603. 10.1046/j.1365-2141.1996.00392.x, 8616023.
43. Feng X, Petraglia AL, Chen M, Byskosh PV, Boos MD, Reder AT. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1. J Neuroimmunol 2002, 129(1-2):205-215.
44. Takaoka A, Mitani Y, Suemori H, Sato M, Yokochi T, Noguchi S, Tanaka N, Taniguchi T. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 2000, 288(5475):2357-2360. 10.1126/science.288.5475.2357, 10875919.
45. Andrews HN, Mullan PB, McWilliams S, Sebelova S, Quinn JE, Gilmore PM, McCabe N, Pace A, Koller B, Johnston PG, Haber DA, Harkin DP. BRCA1 regulates the interferon gamma-mediated apoptotic response. J Biol Chem 2002, 277(29):26225-26232. 10.1074/jbc.M201316200, 12011077.
46. Yan Y, Haas JP, Kim M, Sgagias MK, Cowan KH. BRCA1-induced apoptosis involves inactivation of ERK1/2 activities. J Biol Chem 2002, 277(36):33422-33430. 10.1074/jbc.M201147200, 12082091.
47. Thangaraju M, Kaufmann SH, Couch FJ. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J Biol Chem 2000, 275(43):33487-33496. 10.1074/jbc.M005824200, 10938285.
48. Cheung AM, Hande MP, Jalali F, Tsao MS, Skinnider B, Hirao A, McPherson JP, Karaskova J, Suzuki A, Wakeham A, You-Ten A, Elia A, Squire J, Bristow R, Hakem R, Mak TW. Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis. Cancer Res 2002, 62(21):6194-6204.
49. Park SJ, Beck BD, Saadatzadeh MR, Haneline LS, Clapp DW, Lee SH. Fanconi anemia D2 protein is an apoptotic target mediated by caspases. J Cell Biochem 2011, 112(9):2383-2391. 10.1002/jcb.23161, 3509204, 21520247.
50. Spillare EA, Wang XW, von Kobbe C, Bohr VA, Hickson ID, Harris CC. Redundancy of DNA helicases in p53-mediated apoptosis. Oncogene 2006, 25(14):2119-2123. 10.1038/sj.onc.1209242, 1420682, 16288211.
51. Vilasco M, Communal L, Hugon-Rodin J, Penault-Llorca F, Mourra N, Wu Z, Forgez P, Gompel A. Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. Breast Cancer Res Treat 2013, 142(2):283-296. 10.1007/s10549-013-2722-8, 24166279.
52. Neville MC, McFadden TB, Forsyth I. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 2002, 7(1):49-66. 10.1023/A:1015770423167, 12160086.
53. Mueller CR, Roskelley CD. Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res 2003, 5(1):45-52. 10.1186/bcr557, 154136, 12559046.
54. Noguchi M. Changes in human serum corticosterone and cortisol during pregnancy, labor and delivery. Nihon Sanka Fujinka Gakkai Zasshi 1988, 40(1):14-20.
55. Abou-Samra AB, Pugeat M, Dechaud H, Nachury L, Bouchareb B, Fevre-Montange M, Tourniaire J. Increased plasma concentration of N-terminal beta-lipotrophin and unbound cortisol during pregnancy. Clin Endocrinol (Oxf) 1984, 20(2):221-228. 10.1111/j.1365-2265.1984.tb00077.x, 6713691.
56. D'Anna-Hernandez KL, Ross RG, Natvig CL, Laudenslager ML. Hair cortisol levels as a retrospective marker of hypothalamic-pituitary axis activity throughout pregnancy: comparison to salivary cortisol. Physiol Behav 2011, 104(2):348-353. 10.1016/j.physbeh.2011.02.041, 3118940, 21397617.
57. Carr BR, Parker CR, Madden JD, MacDonald PC, Porter JC. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. Am J Obstet Gynecol 1981, 139(4):416-422.
58. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009, 23(22):2563-2577. 10.1101/gad.1849509, 2779757, 19933147.
59. Pang WW, Hartmann PE. Initiation of human lactation: secretory differentiation and secretory activation. J Mammary Gland Biol Neoplasia 2007, 12(4):211-221. 10.1007/s10911-007-9054-4, 18027076.
60. Buse P, Woo PL, Alexander DB, Reza A, Firestone GL. Glucocorticoid-induced functional polarity of growth factor responsiveness regulates tight junction dynamics in transformed mammary epithelial tumor cells. J Biol Chem 1995, 270(47):28223-28227. 10.1074/jbc.270.47.28223, 7499317.
61. Woo PL, Ching D, Guan Y, Firestone GL. Requirement for Ras and phosphatidylinositol 3-kinase signaling uncouples the glucocorticoid-induced junctional organization and transepithelial electrical resistance in mammary tumor cells. J Biol Chem 1999, 274(46):32818-32828. 10.1074/jbc.274.46.32818, 10551843.
62. Stocklin E, Wissler M, Gouilleux F, Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996, 383(6602):726-728. 10.1038/383726a0, 8878484.
63. Wyszomierski SL, Yeh J, Rosen JM. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol Endocrinol 1999, 13(2):330-343. 10.1210/mend.13.2.0232, 9973262.
64. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 1997, 11(2):179-186. 10.1101/gad.11.2.179, 9009201.
65. Feng Z, Marti A, Jehn B, Altermatt HJ, Chicaiza G, Jaggi R. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J Cell Biol 1995, 131(4):1095-1103. 10.1083/jcb.131.4.1095, 2200011, 7490285.
66. Tanaka H, Makino Y, Miura T, Hirano F, Okamoto K, Komura K, Sato Y, Makino I. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J Immunol 1996, 156(4):1601-1608.
67. Eickelberg O, Roth M, Lorx R, Bruce V, Rudiger J, Johnson M, Block LH. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999, 274(2):1005-1010. 10.1074/jbc.274.2.1005, 9873044.
68. Kotitschke A, Sadie-Van Gijsen H, Avenant C, Fernandes S, Hapgood JP. Genomic and nongenomic cross talk between the gonadotropin-releasing hormone receptor and glucocorticoid receptor signaling pathways. Mol Endocrinol 2009, 23(11):1726-1745. 10.1210/me.2008-0462, 19812390.
69. Verhoog NJ, Du Toit A, Avenant C, Hapgood JP. Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response. J Biol Chem 2011, 286(22):19297-19310. 10.1074/jbc.M110.193672, 3103308, 21474440.
70. Bujalska IJ, Walker EA, Tomlinson JW, Hewison M, Stewart PM. 11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol. Endocr Res 2002, 28(4):449-461. 10.1081/ERC-120016822, 12530648.
71. Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008, 3(2):97-106. 10.4161/epi.3.2.6034, 18536531.
72. Pan D, Kocherginsky M, Conzen SD. Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res 2011, 71(20):6360-6370. 10.1158/0008-5472.CAN-11-0362, 3514452, 21868756.
73. Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, Bernard V, McPherson A, Shumansky K, Crisan A, Giuliany R, Heravi-Moussavi A, Rosner J, Lai D, Birol I, Varhol R, Tam A, Dhalla N, Zeng T, Ma K, Chan SK, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012, 486(7403):395-399. 3863681, 22495314.
74. Nesset KA, Perri AM, Mueller CR. Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors. Epigenetics 2014, 9(6). in press.